1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ertugliflozin + sitagliptin
Trade Name:
Steglujan
Manufacturer/Distributor:
Merck Canada
Classification:
Oral blood glucose lowering agents
ATC Class:
A10BD24 - sitagliptin + ertugliflozin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/05/22
Date Marketed in Canada (yyyy/mm/dd):
2018/05/22
Presentation:
Tablet: 5 mg ertugliflozin + 100 mg sitagliptin. DIN: 02475901
Tablet: 15 mg ertugliflozin + 100 mg sitagliptin. DIN: 02475928
Comments:
For use in combination with metformin as an adjunct to diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus who are inadequately controlled on metformin and sitagliptin, or already controlled with metformin, sitagliptin and ertugliflozin, as individual components.
Back to:
Drug Product Listings 
